Home/Filings/4/0001225208-22-002220
4//SEC Filing

Mammen Mathai 4

Accession 0001225208-22-002220

CIK 0000200406other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 8:03 PM ET

Size

7.9 KB

Accession

0001225208-22-002220

Insider Transaction Report

Form 4
Period: 2022-02-14
Mammen Mathai
EVP, Pharm, R&D
Transactions
  • Exercise/Conversion

    Common Stock

    2022-02-14+7,41839,895 total
  • Tax Payment

    Common Stock

    2022-02-14$168.85/sh2,335$394,26537,560 total
  • Exercise/Conversion

    Restricted Share Units

    2022-02-147,4180 total
    From: 2022-02-11Common Stock (7,418 underlying)
Footnotes (2)
  • [F1]Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
  • [F2]Shares withheld for payment of taxes upon vesting of Restricted Share Units.

Documents

1 file

Issuer

JOHNSON & JOHNSON

CIK 0000200406

Entity typeother

Related Parties

1
  • filerCIK 0001421050

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:03 PM ET
Size
7.9 KB